Medscape Conference Coverage, based on selected sessions at:
Digestive Disease Week (DDW) 2008
May 17 - 22, 2008, San Diego, California
This activity is not sanctioned by, nor a part of, Digestive Disease Week. Conference news does not receive grant support and is produced independently.
Physicians - maximum of 1.0 AMA PRA Category 1 credit(s)™
New Directions in Viral Hepatitis Tram T. Tran, MD
New Insights Into NAFLD: An Expert Interview With William F. Balistreri, MD William F. Balistreri, MD
Daily Session Coverage
Hepatitis C: New Clinical Insights Nancy Reau, MD, assesses the latest information regarding the management and clinical evaluation of patients with chronic hepatitis C, as based on data presented at DDW 2008.
News on Celiac Disease: Where Are We? Where Are We Going?Alessio Fasano, MD, explores the latest issues regarding this immune-mediated enteropathy, with a view toward implications for clinical practice, as based on key proceedings at DDW 2008.
Clinical Advances in Biliary and Pancreatic DisordersJohn Baillie, MB, ChB, FRCP, FASGE, explores topical issues in the diagnosis and treatment of pancreatic/biliary disease, as based on key sessions at DDW 2008.
Prateek Sharma, MD, comments on the latest data about this clinically important lesion, with a view toward implications for screening and surveillance, as framed by data from DDW 2008.
David A. Schwartz, MD, discusses current and emerging issues in anti-TNF-alpha therapy for Crohn's disease, as framed by new data presented at DDW 2008.
New PPI Heals Erosive Esophagitis Better Than Older FormulationThe results of a meta-analysis of two phase III studies, announced here during Digestive Disease Week 2008, show that the investigational proton pump inhibitor TAK-390mr (TAP Pharmaceutical Products, Inc., Lake Forest, Illinois) achieves better healing rates and maintains longer pH control than lansoprazole (Prevacid, TAP Pharmaceutical Products, Inc.).
Reuters Health, May 22, 2008
Embryonic Stem Cells Fully Differentiated Into Pure, Mature HepatocytesA team out of the University of Edinburgh, Scotland reports that it has successfully differentiated human embryonic stem cells into mature hepatocytes that produce adult levels of enzymes, proteins and other markers of fully differentiated liver cells.
Reuters Health, May 22, 2008
Prophylactic NSAID Reduces Post-Endoscopy PancreatitisA single-dose of a non-steroidal anti-inflammatory drug (NSAID), administered rectally just prior to endoscopic retrograde cholangiopancreatography, can reduce the risk of procedure-related pancreatitis by 64%, investigators announced over the weekend here as temperatures climbed to a record-high 100 degrees.
Reuters Health, May 19, 2008
Legal Disclaimer
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of Digestive Disease Week. These materials and the related activity are not sanctioned by Digestive Disease Week or the commercial supporter of the conference and do not constitute an official part of that conference.
